GlassScriptPhysician profile
Alexander Reid
NPI 1649775461
$1,168.57
in general payments reported to CMS, 2019-2025
18 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $53.00 · 2022: $46.30 · 2023: $187 · 2024: $483 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $264.17 | 2019-2025 | |
| Ucb, INC. | $154.01 | 2024-2025 | Bimzelx |
| Janssen Biotech, INC. | $144.83 | 2023-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $108.02 | 2024-2025 | |
| Lilly USA, LLC | $58.77 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| Organon LLC | $58.73 | 2023-2024 | Hadlima |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $54.61 | 2024-2025 | Siliq, Cabtreo |
| Vyne Pharmaceuticals INC. | $53.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $46.30 | 2022 | |
| Amgen INC. | $38.17 | 2024-2025 | Otezla |
| Abbvie INC. | $36.70 | 2023-2024 | |
| Leo Pharma INC. | $26.83 | 2024 | Adbry |
| Galderma Laboratories, L.P. | $24.99 | 2024 | Aklief |
| Kerecis Limited | $24.54 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.95 | 2025 | Spevigo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $19.25 | 2023 | Opzelura |
| Gilead Sciences, INC. | $18.04 | 2025 | Trodelvy |
| Journey Medical Corporation | $14.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.